Label

How We Work

Grant

Back

Print

Sanofi Pasteur, S.A.


October 2015
to explore the technical and regulatory feasibility of Micropellet technology for the development of cost-effective novel combination vaccines that are thermal stable
$1,795,242
35
Vaccine Development
Global Health
Lyon
http://www.sanofipasteur.com

Visit Our Blog